Neil M Bessler

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab
    Neil M Bressler
    Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 120:160-8. 2013
  2. ncbi request reprint Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
    Neil M Bressler
    Retina Division, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Retina 32:1821-8. 2012
  3. ncbi request reprint Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group
    Sharon D Solomon
    Johns Hopkins University School of Medicine, 550 N Broadway, Ste 115, Baltimore, MD 21205 2005, USA
    Arch Ophthalmol 125:1323-30. 2007
  4. pmc Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2
    Neil M Bressler
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2005, USA
    Arch Ophthalmol 122:857-63. 2004
  5. ncbi request reprint Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients
    Neil M Bessler
    Baltimore, MD 21205, USA
    Retina 24:512-20. 2004
  6. ncbi request reprint Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6
    Susan B Bressler
    Department of Ophthalmology, The Johns Hopkins University School of Medicine and The Johns Hopkins Hospital, Baltimore, MD 20205 2002, USA
    Arch Ophthalmol 122:325-9. 2004
  7. ncbi request reprint Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
    Keven J Blinder
    Am J Ophthalmol 136:407-18. 2003
  8. doi request reprint Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial
    Neil M Bressler
    Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 2002, USA
    Arch Ophthalmol 127:13-21. 2009
  9. ncbi request reprint Retinal pigment epithelium tumorlike lesion arising from an area treated with laser photocoagulation
    Eyal Margalit
    Department of Ophthalmology, Johns Hopkins University School of Medicine, 550 N Broadway, Suite 115, Baltimore, MD 21205 2002, USA
    Arch Ophthalmol 121:130-2. 2003
  10. pmc Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13
    Neil M Bressler
    SST Coordinating Center, Wilmer Clinical Trials and Biometry, 550 North Broadway, 9th Floor, Baltimore, MD 21205 2010, USA
    Ophthalmology 111:1993-2006. 2004

Detail Information

Publications85

  1. doi request reprint Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab
    Neil M Bressler
    Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 120:160-8. 2013
    ..To determine the impact of ranibizumab on driving status, driving ability perception, and having 20/40 vision or better in patients with choroidal neovascularization resulting from age-related macular degeneration (AMD)...
  2. ncbi request reprint Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials
    Neil M Bressler
    Retina Division, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Retina 32:1821-8. 2012
    ..To analyze cerebrovascular accidents (CVAs) pooled from large, randomized, controlled clinical trials of ranibizumab treatment for neovascular age-related macular degeneration...
  3. ncbi request reprint Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group
    Sharon D Solomon
    Johns Hopkins University School of Medicine, 550 N Broadway, Ste 115, Baltimore, MD 21205 2005, USA
    Arch Ophthalmol 125:1323-30. 2007
    ..To describe incident choroidal neovascular lesions in fellow eyes of participants in the Submacular Surgery Trials who had age-related macular degeneration (AMD)...
  4. pmc Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2
    Neil M Bressler
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2005, USA
    Arch Ophthalmol 122:857-63. 2004
    ..To compare the performance of community- vs university-based clinical centers in 3 multicenter randomized clinical trials of intraocular surgery...
  5. ncbi request reprint Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients
    Neil M Bessler
    Baltimore, MD 21205, USA
    Retina 24:512-20. 2004
    ..The Verteporfin in Age-related Macular Degeneration (VAM) Study was designed to provide expanded access to verteporfin therapy after beneficial results for these cases were reported but before regulatory approval in North America...
  6. ncbi request reprint Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6
    Susan B Bressler
    Department of Ophthalmology, The Johns Hopkins University School of Medicine and The Johns Hopkins Hospital, Baltimore, MD 20205 2002, USA
    Arch Ophthalmol 122:325-9. 2004
    ..To determine if there is a rationale for monitoring patients with age-related macular degeneration who have a minimally classic subfoveal choroidal neovascular lesion and do not receive treatment at initial examination...
  7. ncbi request reprint Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
    Keven J Blinder
    Am J Ophthalmol 136:407-18. 2003
    ....
  8. doi request reprint Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial
    Neil M Bressler
    Department of Ophthalmology, Retina Division, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 2002, USA
    Arch Ophthalmol 127:13-21. 2009
    ..To compare patient-reported visual function in those with neovascular age-related macular degeneration treated with ranibizumab or verteporfin photodynamic therapy (PDT)...
  9. ncbi request reprint Retinal pigment epithelium tumorlike lesion arising from an area treated with laser photocoagulation
    Eyal Margalit
    Department of Ophthalmology, Johns Hopkins University School of Medicine, 550 N Broadway, Suite 115, Baltimore, MD 21205 2002, USA
    Arch Ophthalmol 121:130-2. 2003
  10. pmc Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13
    Neil M Bressler
    SST Coordinating Center, Wilmer Clinical Trials and Biometry, 550 North Broadway, 9th Floor, Baltimore, MD 21205 2010, USA
    Ophthalmology 111:1993-2006. 2004
    ....
  11. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3
    Neil M Bressler
    Wilmer Photograph Reading Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 2002, USA
    Arch Ophthalmol 120:1443-54. 2002
    ....
  12. ncbi request reprint Advantages and potential dangers of presentation before publication: third in a series on editorship
    Neil M Bressler
    Department of Ophthalmolgoy, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 2002, USA
    Arch Ophthalmol 122:1045-8. 2004
  13. doi request reprint Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR
    Neil M Bressler
    Retina Division, Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 0005, USA
    Ophthalmology 117:747-56.e4. 2010
    ....
  14. ncbi request reprint Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration
    Marta M Gilson
    Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 114:1713-21. 2007
    ....
  15. ncbi request reprint Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study
    Philip J Rosenfeld
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami School of Medicine, Miami, FL 33136, USA
    Ophthalmology 111:1725-33. 2004
    ....
  16. ncbi request reprint Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children
    Karin F Mimouni
    Retinal Vascular Center, Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland 21205 2002, USA
    Am J Ophthalmol 135:900-2. 2003
    ..To report the safety of photodynamic therapy with verteporfin in three children...
  17. doi request reprint Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial
    Maureen G Maguire
    Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 3309, USA
    Ophthalmology 115:1468-73, 1473.e1-2. 2008
    ..To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT)...
  18. ncbi request reprint Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4
    Li Ming Dong
    Wilmer Clinical Trials and Biometry, The Wilmer Ophthalmologic Institute, 550 N Broadway, 9th Floor, Baltimore, MD 21205 2010, USA
    Am J Ophthalmol 138:91-108. 2004
    ....
  19. doi request reprint Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration
    Margaret A Chang
    Retina Division and Dana Center for Preventive Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 30:1171-6. 2010
    ..To determine the safety and effect of ranibizumab on predominantly hemorrhagic choroidal neovascular lesions due to age-related macular degeneration...
  20. ncbi request reprint Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16
    Hans E Grossniklaus
    Department of Ophthalmology, Emory University School of Medicine, 428 Emory Eye Center, 1365 Clifton Road, Atlanta, GA 30322, USA
    Am J Ophthalmol 141:93-104. 2006
    ..To compare the fundus photographic and fluorescein angiographic features with the histologic findings in eyes from patients enrolled in the Submacular Surgery Trials (SST)...
  21. ncbi request reprint Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin
    Michael P Blair
    Retinal Vascular Center, Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Retina 24:501-6. 2004
    ..To describe visual acuity and angiographic outcomes of juxtafoveal choroidal neovascularization (CNV) treated with photodynamic therapy and verteporfin (PDT)...
  22. pmc Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12
    Päivi H Miskala
    SST Coordinating Center, 550 North Broadway, 9th Floor, Baltimore, MD 21205 2010, USA
    Ophthalmology 111:1981-92. 2004
    ....
  23. ncbi request reprint Choroidal neovascularization after central retinal vein occlusion in a 47-year-old man
    David A DiLoreto
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, 550 N Broadway, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:1398-401. 2004
  24. pmc The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials
    Janet S Sunness
    Richard E Hoover Rehabilitation Services for Low Vision and Blindness, Greater Baltimore Medical Center, Baltimore, Maryland 21204, USA
    Ophthalmology 114:271-7. 2007
    ..To report the enlargement rate of geographic atrophy (GA) over time, its relationship to size of atrophy at baseline and to prior enlargement rate, and the implications for designing future treatment trials for GA...
  25. pmc Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration
    Janet S Sunness
    The Richard E Hoover Rehabilitation Services for Low Vision and Blindness, Greater Baltimore Medical Center, Baltimore, Maryland 21204, USA
    Ophthalmology 115:1480-8, 1488.e1-2. 2008
    ..To show that low luminance visual dysfunction is predictive of subsequent visual acuity (VA) loss in eyes with geographic atrophy (GA) resulting from age-related macular degeneration (AMD)...
  26. doi request reprint Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration
    Neil M Bressler
    Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Arch Ophthalmol 129:709-17. 2011
    ..To estimate the number of non-Hispanic white individuals in the United States avoiding legal blindness and visual impairment from neovascular age-related macular degeneration (AMD) with ranibizumab availability...
  27. ncbi request reprint Evaluation of the traveling vision examiner program in the submacular surgery trials pilot study
    Peggy R Orr
    The Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2010, USA
    Ophthalmic Epidemiol 12:47-57. 2005
    ..To describe methods and results and to assess the value of a Traveling Vision Examiner (TVE) Program designed to provide masked vision measurements by expert vision examiners who were independent of, and traveled to, local clinical centers...
  28. pmc Guidelines for interpreting retinal photographs and coding findings in the Submacular Surgery Trials (SST): SST report no. 8
    Sharon D Solomon
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2005, USA
    Retina 25:253-68. 2005
    ....
  29. ncbi request reprint Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice
    Oliver D Schein
    Department of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 9019, USA
    Arch Ophthalmol 123:58-63. 2005
    ..To assess adherence to Food and Drug Administration-approved indications and Centers for Medicare & Medicaid Services policy through June 2001 regarding the use of photodynamic therapy in Medicare beneficiaries...
  30. ncbi request reprint Designing clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history study
    Janet S Sunness
    Richard E Hoover Rehabilitation Services for Low Vision and Blindness, Greater Baltimore Medical Center, Baltimore, Maryland 21204, USA
    Retina 27:204-10. 2007
    ..To derive information from the Geographic Atrophy (GA) Natural History Study that is relevant to recruiting patients and designing clinical trials for GA...
  31. doi request reprint Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization
    Rahul N Khurana
    Retina Division, Wilmer Eye Institute, Johns Hopkins Medical Institute, Baltimore, Maryland 21287, USA
    Ophthalmology 117:1376-80. 2010
    ....
  32. doi request reprint A cost-effectiveness analysis of three treatments for age-related macular degeneration
    Emily W Gower
    Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Retina 30:212-21. 2010
    ....
  33. doi request reprint Antiangiogenic approaches to age-related macular degeneration today
    Neil M Bressler
    The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ophthalmology 116:S15-23. 2009
    ..A subsequent review in this series discusses other therapies for CNV being considered in the future...
  34. doi request reprint Risk factors for rhegmatogenous retinal detachment in the submacular surgery trials: SST report No. 22
    Sharon D Solomon
    Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 29:819-24. 2009
    ..To identify risk factors associated with the development of rhegmatogenous retinal detachment (RRD) in patients enrolled in the Submacular Surgery Trials...
  35. doi request reprint Surgical removal vs observation for idiopathic or ocular histoplasmosis syndrome-associated subfoveal choroidal neovascularization: Vision Preference Value Scale findings from the randomized SST Group H Trial: SST Report No. 17
    Eric B Bass
    Department of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
    Arch Ophthalmol 126:1626-32. 2008
    ..To determine whether patients receiving observation vs surgery for subfoveal choroidal neovascularization that was idiopathic or associated with histoplasmosis differed in preference values assigned to their health and vision status...
  36. doi request reprint Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the macular photocoagulation study
    Joan L Jefferys
    The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmic Epidemiol 15:191-201. 2008
    ....
  37. doi request reprint Patient-reported outcomes among sham vs no-treatment controls from randomized trials
    Barbara S Hawkins
    Wilmer Clinical Trials and Biometry, Wilmer Eye Institute, School of Medicine, Johns Hopkins University, 550 N Broadway, Baltimore, MD 21205 2010, USA
    Arch Ophthalmol 129:200-5. 2011
    ....
  38. ncbi request reprint Comparison of methods to identify incident cataract in eyes of patients with neovascular maculopathy: Submacular Surgery Trials Report No. 18
    Ashley L Mann
    Submacular Surgery Trials Chair s Office, Wilmer Eye Institute, Johns Hopkins University, 550 North Broadway, Suite 115, Baltimore, MD 21205, USA
    Ophthalmology 115:127-33. 2008
    ..To describe and compare methods used to monitor development and progression of presumed vision-limiting lens opacity in study eyes of Submacular Surgery Trials (SST) patients...
  39. pmc Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6
    Eric B Bass
    Arch Ophthalmol 122:1856-67. 2004
    ....
  40. ncbi request reprint Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration
    Päivi H Miskala
    Department of Ophthalmology, Wilmer Clinical Trials and Biometry, The Johns Hopkins University School of Medicine, 550 N Broadway, Ninth Floor, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:758-66. 2004
    ..To estimate the relative contributions of central vision loss and general health to vision-targeted quality of life as measured by the National Eye Institute Visual Function Questionnaire (NEI-VFQ)...
  41. ncbi request reprint Iatrogenic choroidal neovascularization occurring in patients undergoing macular surgery
    Eugene W M Ng
    The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 22:711-8. 2002
    ..To report three cases of choroidal neovascularization (CNV) that occurred following surgical disruption of Bruch membrane during macular surgery...
  42. doi request reprint Visual acuity outcomes among sham vs no-treatment controls from randomized trials
    Barbara S Hawkins
    Wilmer Eye Institute, School of Medicine, Johns Hopkins University, 550 N Broadway, Room 930, Baltimore, MD 21205 2010, USA
    Arch Ophthalmol 127:725-31. 2009
    ..To compare 2-year visual acuity outcomes between similar participants assigned to sham and no-treatment control arms in randomized clinical trials...
  43. pmc Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11
    Barbara S Hawkins
    SST Coordinating Center, Wilmer Clinical Trials and Biometry, 550 North Broadway, 9th Floor, Baltimore, MD 21205 2010, USA
    Ophthalmology 111:1967-80. 2004
    ....
  44. ncbi request reprint Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials?
    Päivi H Miskala
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Ophthalmol 137:961-3. 2004
    ..To assess whether treatment comparison of National Eye Institute Visual Function Questionnaire (NEI-VFQ) scores in a clinical trial is influenced by general health to warrant adjusting for it...
  45. pmc Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14
    Ashley L Childs
    SST Coordinating Center, 550 North Broadway, 9th Floor, Baltimore, MD 21205, USA
    Ophthalmology 111:2007-14. 2004
    ....
  46. pmc Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1
    Päivi H Miskala
    Submacular Surgery Trials Coordinating Center, Wilmer Clinical Trials and Biometry, Baltimore, MD 21205, USA
    Arch Ophthalmol 121:531-9. 2003
    ..The National Eye Institute Visual Function Questionnaire (NEI-VFQ) measures vision-targeted quality of life, but it is unclear whether it is sensitive to changes within individuals over time...
  47. ncbi request reprint Large submacular hemorrhages after verteporfin therapy
    Diana V Do
    The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 137:558-60. 2004
    ....
  48. ncbi request reprint Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography
    Stephen J Kim
    Retina Division, Wilmer Eye Institute Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:881-9. 2007
    ..To assess the incidence or progression of macular edema (ME) after cataract surgery in diabetic patients using optical coherence tomography (OCT) and correlating this with degree of diabetic retinopathy or other risk factors...
  49. ncbi request reprint Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma
    Prem S Subramanian
    Neuro Ophthalmology Unit, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Ophthalmology 111:565-7. 2004
    ..To report a patient with radiation retinopathy after fractionated stereotactic radiotherapy for treatment of optic nerve sheath meningioma (ONSM)...
  50. ncbi request reprint Use of best and final visual acuity outcomes in ophthalmological research
    David A DiLoreto
    Retinal Vascular Center, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine and Hospital, Baltimore, MD 21205, USA
    Arch Ophthalmol 121:1586-90. 2003
    ....
  51. ncbi request reprint Foveal congenital hypertrophy of the retinal pigment epithelium in the setting of geographic atrophy from age-related macular degeneration
    Rajendra S Apte
    Retinal Vascular Center, The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 135:120-1. 2003
    ..To report a case of presumed congenital hypertrophy of the retinal pigment epithelium in the fovea of an 88-year-old woman in the setting of geographic atrophy from age-related macular degeneration...
  52. ncbi request reprint Early detection and treatment of neovascular age-related macular degeneration
    Neil M Bressler
    The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore 21205 2005, USA
    J Am Board Fam Pract 15:142-52. 2002
    ..Verteporfin therapy is a new treatment option involving photodynamic therapy that was recently shown to be relatively safe and effective in reducing the risk of vision loss in selected cases...
  53. ncbi request reprint Patients' preferences in choosing therapy for retinal vein occlusions
    Margaret A Chang
    Department of Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 27:789-97. 2007
    ..The purpose of this study was to assess preference values for vein occlusions with macular edema and to determine how this may affect patient perceptions of potential treatments...
  54. doi request reprint A method of reporting macular edema after cataract surgery using optical coherence tomography
    Stephen J Kim
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Retina 28:870-6. 2008
    ..To validate a method of reporting postcataract macular edema (ME) using optical coherence tomography (OCT)...
  55. ncbi request reprint Optical coherence tomography and cataract surgery
    Stephen J Kim
    Department of Ophthalmology, Vanderbilt University, Nashville, Tennessee 37232 8808, USA
    Curr Opin Ophthalmol 20:46-51. 2009
    ..To provide an unstructured review of the recent literature on the role of optical coherence tomography (OCT) in cataract surgery with specific focus on cystoid macular edema (CME) on the basis of expert opinion of the authors...
  56. ncbi request reprint Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography
    Justin C Brown
    Retinal Vascular Center, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 2002, USA
    Arch Ophthalmol 122:330-5. 2004
    ..To compare contact lens biomicroscopy with optical coherence tomography (OCT) for the detection of diabetic foveal edema...
  57. ncbi request reprint Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center
    Diana V Do
    Department of Ophthalmology, Retina Division of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Am J Ophthalmol 141:951-3. 2006
    ..To describe awareness of hemoglobin A1c (HbA1c) among patients receiving eye care at a tertiary ophthalmic center for diabetic eye disease...
  58. ncbi request reprint Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2
    Irene Barbazetto
    Medizinische Universitat zu Lubeck, Klinik fur Augenheilkunde, Lubeck, Germany
    Arch Ophthalmol 121:1253-68. 2003
    ....
  59. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3
    Kevin J Blinder
    Ophthalmology 110:667-73. 2003
    ..To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia...
  60. ncbi request reprint Improvement after verteporfin therapy
    Rajiv Anand
    Arch Ophthalmol 121:415-6. 2003
  61. ncbi request reprint Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4
    Gary S Rubin
    Institute of Ophthalmology, University College London, United Kingdom
    Retina 22:536-44. 2002
    ..This report presents detailed analyses of 24-month contrast sensitivity outcomes in these patients...
  62. ncbi request reprint Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin
    Miki Sawa
    Department of Ophthalmology, Osaka University Medical School, Room E7, 2 2 Yamadaoka Suita, Osaka 565 0871, Japan
    Arch Ophthalmol 120:1588-90. 2002
  63. ncbi request reprint Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5
    Mark S Blumenkranz
    Arch Ophthalmol 120:1307-14. 2002
    ..To report vision and safety outcomes from an extension of a 2-year investigation evaluating verteporfin photodynamic therapy in patients with age-related macular degeneration with subfoveal choroidal neovascularization (CNV)...
  64. ncbi request reprint Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series
    David A Saperstein
    Ophthalmology 109:1499-505. 2002
    ..To evaluate the safety and effect on visual acuity of photodynamic therapy with verteporfin (Visudyne, Novartis AG) in patients with subfoveal choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS)...
  65. pmc Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema
    Matthew D Davis
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA
    Invest Ophthalmol Vis Sci 49:1745-52. 2008
    ..To explore the correlation between optical coherence tomography (OCT) and stereoscopic fundus photographs (FP) for the assessment of retinal thickening (RT) in diabetic macular edema (DME) within a clinical trial...
  66. pmc Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11
    Neil M Bressler
    Arch Ophthalmol 121:1621-4. 2003
    ....
  67. ncbi request reprint Changes in lesion size after submacular surgery for subfoveal choroidal neovascularization in the submacular surgery trials pilot study
    Srinivas R Sadda
    Doheny Retina Institute, Doheny Eye Institute, Los Angeles, California, USA
    Retina 24:888-99. 2004
    ..To compare the size of subfoveal lesions based on photographic documentation before and after submacular surgery of choroidal neovascularization (CNV) lesions...
  68. pmc Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SS
    Barbara S Hawkins
    Arch Ophthalmol 122:1597-611. 2004
    ....
  69. ncbi request reprint Verteporfin in Photodynamic Therapy: report no. 5
    Francesco Bandello
    Ophthalmology 111:2144. 2004
  70. ncbi request reprint Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial
    Mohammad Azab
    Arch Ophthalmol 123:448-57. 2005
    ....
  71. ncbi request reprint Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: submacular surgery trials report no. 7
    Hans E Grossniklaus
    Montgomery Ophthalmic Pathology Labotratory, BT0428 Emory Eye Center, 1365 Clifton Road NE, Atlanta, GA 30322, USA
    Arch Ophthalmol 123:914-21. 2005
    ..To identify the histologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions from patients enrolled in the Submacular Surgery Trials and to compare them with clinical data...
  72. ncbi request reprint Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study
    Yair Alster
    Clin Reg Consulting Services Inc, Irvine, California, USA
    Ophthalmology 112:1758-65. 2005
    ....
  73. ncbi request reprint Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7
    Neil M Bressler
    Arch Ophthalmol 123:1283-5. 2005
  74. ncbi request reprint Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy
    Michael D Ober
    LuEsther T Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA
    Ophthalmology 112:2088-94. 2005
    ..To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC)...
  75. ncbi request reprint Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No.
    Dante J Pieramici
    Arch Ophthalmol 124:660-4. 2006
    ....
  76. ncbi request reprint Verteporfin therapy for CNV secondary to OHS
    David A Saperstein
    Ophthalmology 113:2371.e1-3. 2006
  77. ncbi request reprint New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence
    Gianni Virgili
    Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Florence, Italy
    Acta Ophthalmol Scand 85:6-20. 2007
    ....
  78. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Vert
    Mohammad Azab
    Retina 24:1-12. 2004
    ....
  79. ncbi request reprint Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3
    Jennifer J Arnold
    Am J Ophthalmol 137:683-96. 2004
    ....
  80. ncbi request reprint Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic thera
    Neil M Bressler
    Am J Ophthalmol 133:168-9. 2002
  81. ncbi request reprint Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial
    Tom S Chang
    Retina Institute of California, 800 S Fairmount Ave, Ste 312, Pasadena, CA 91105, USA
    Arch Ophthalmol 125:1460-9. 2007
    ..To examine the effects of ranibizumab on patient-reported visual function using the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25) in patients with neovascular age-related macular degeneration (AMD)...
  82. ncbi request reprint Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study
    Philip J Rosenfeld
    Bascom Palmer Eye Institute, Miami, FL, USA
    Am J Ophthalmol 144:970-972. 2007
    ..To compare photodynamic therapy (PDT) with verteporfin (Visudyne; Novartis Pharma AG, Basel, Switzerland) using either standard or delayed light application...
  83. pmc Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10
    Barbara S Hawkins
    Arch Ophthalmol 122:1616-28. 2004
    ....